West Pharmaceutical Services Reports Strong Q2 Earnings and Revenue Beats
West Pharmaceutical Services (WST) reported better-than-expected Non-GAAP earnings per share (EPS) of $2.37, beating estimates by $0.29, along with revenue of $872.3 million that exceeded forecasts by $32.32 million and grew 13.8% year-over-year.
Tickers: $WST
Topics: earnings outlook revenue growth